Residual Corticosteroid Production in Autoimmune Addison Disease.
Adrenal failure
Autoimmune Addison disease
adrenal steroids
cortisol
primary adrenal insufficiency
residual function
Journal
The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362
Informations de publication
Date de publication:
01 07 2020
01 07 2020
Historique:
received:
31
01
2020
accepted:
07
05
2020
pubmed:
12
5
2020
medline:
4
2
2021
entrez:
12
5
2020
Statut:
ppublish
Résumé
Contrary to current dogma, growing evidence suggests that some patients with autoimmune Addison disease (AAD) produce corticosteroids even years after diagnosis. To determine frequencies and clinical features of residual corticosteroid production in patients with AAD. Two-staged, cross-sectional clinical study in 17 centers (Norway, Sweden, and Germany). Residual glucocorticoid (GC) production was defined as quantifiable serum cortisol and 11-deoxycortisol and residual mineralocorticoid (MC) production as quantifiable serum aldosterone and corticosterone after > 18 hours of medication fasting. Corticosteroids were analyzed by liquid chromatography-tandem mass spectrometry. Clinical variables included frequency of adrenal crises and quality of life. Peak cortisol response was evaluated by a standard 250 µg cosyntropin test. Fifty-eight (30.2%) of 192 patients had residual GC production, more common in men (n = 33; P < 0.002) and in shorter disease duration (median 6 [0-44] vs 13 [0-53] years; P < 0.001). Residual MC production was found in 26 (13.5%) patients and associated with shorter disease duration (median 5.5 [0.5-26.0] vs 13 [0-53] years; P < 0.004), lower fludrocortisone replacement dosage (median 0.075 [0.050-0.120] vs 0.100 [0.028-0.300] mg; P < 0.005), and higher plasma renin concentration (median 179 [22-915] vs 47.5 [0.6-658.0] mU/L; P < 0.001). There was no significant association between residual production and frequency of adrenal crises or quality of life. None had a normal cosyntropin response, but peak cortisol strongly correlated with unstimulated cortisol (r = 0.989; P < 0.001) and plasma adrenocorticotropic hormone (ACTH; r = -0.487; P < 0.001). In established AAD, one-third of the patients still produce GCs even decades after diagnosis. Residual production is more common in men and in patients with shorter disease duration but is not associated with adrenal crises or quality of life.
Identifiants
pubmed: 32392298
pii: 5835888
doi: 10.1210/clinem/dgaa256
pmc: PMC7274491
pii:
doi:
Substances chimiques
Adrenal Cortex Hormones
0
Cosyntropin
16960-16-0
Banques de données
ClinicalTrials.gov
['NCT03793114']
Types de publication
Clinical Trial
Journal Article
Multicenter Study
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Endocrine Society 2020.
Références
N Engl J Med. 2004 May 13;350(20):2068-79
pubmed: 15141045
J Clin Endocrinol Metab. 2012 Oct;97(10):E1927-32
pubmed: 22767640
Health Econ. 1993 Oct;2(3):217-27
pubmed: 8275167
Endocr Connect. 2018 May;7(5):617-629
pubmed: 29622661
Clin Chim Acta. 2017 Jul;470:115-124
pubmed: 28479316
J Clin Endocrinol Metab. 2018 Apr 1;103(4):1696-1703
pubmed: 29452421
Clin Endocrinol (Oxf). 2002 Jun;56(6):787-91
pubmed: 12072049
J Urol. 2018 May;199(5):1357-1358
pubmed: 29428631
Endocr Rev. 2015 Oct;36(5):564-91
pubmed: 26357922
J Steroid Biochem Mol Biol. 2020 Apr;198:105553
pubmed: 31778802
J Clin Endocrinol Metab. 2020 Apr 1;105(4):
pubmed: 31863094
Endocr Connect. 2013 Jun 14;2(3):125-136
pubmed: 23825158
Clin Endocrinol (Oxf). 2019 Sep;91(3):383-390
pubmed: 31059146
Clin Endocrinol (Oxf). 2011 Apr;74(4):434-7
pubmed: 21114513
J Clin Endocrinol Metab. 2012 Feb;97(2):568-76
pubmed: 22090270
Clin Endocrinol (Oxf). 2013 Jun;78(6):831-7
pubmed: 23134110
J Clin Endocrinol Metab. 2017 Feb 1;102(2):379-389
pubmed: 27870550
Endocr Rev. 2011 Feb;32(1):81-151
pubmed: 21051590
Eur J Endocrinol. 2010 Mar;162(3):597-602
pubmed: 19955259
J Clin Endocrinol Metab. 2014 Jan;99(1):111-8
pubmed: 24170102
Ann N Y Acad Sci. 2006 Nov;1083:165-84
pubmed: 17148739
J Clin Endocrinol Metab. 2009 Dec;94(12):4882-90
pubmed: 19858318
Nat Rev Immunol. 2016 Oct;16(10):626-38
pubmed: 27546235
Endocr Rev. 2019 Aug 1;40(4):973-987
pubmed: 30882882
J Intern Med. 2014 Feb;275(2):104-15
pubmed: 24330030
Cell Stem Cell. 2019 Aug 1;25(2):290-296.e2
pubmed: 31104943
J Clin Endocrinol Metab. 2020 Feb 1;105(2):
pubmed: 31532828
J Clin Endocrinol Metab. 2020 Jan 1;105(1):
pubmed: 31613957
Diabetologia. 2019 Apr;62(4):567-577
pubmed: 30767048
Clin Endocrinol (Oxf). 2018 Jul;89(1):30-35
pubmed: 29682773
J Clin Endocrinol Metab. 2019 Jun 1;104(6):2031-2040
pubmed: 30608542